Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/2162402X.2017.1353856 http://scihub22266oqcxt.onion/10.1080/2162402X.2017.1353856 C5665082!5665082!29123965     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncoimmunology 2017 ; 6 (10): ä Nephropedia Template TP {{tp|p=29123965|t=2017. Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia |pdf=|usr=}}{{29123965}} gab.com Text Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia JO: Oncoimmunology http://www.kidney.de/pget.php?&tw=1&pmid=29123965 #FOAvip Chronic lymphocytic leukemia (CLL) is associated with a profound dysregulation of the immune system. Loss of T cell function is frequently caused in cancer by sustained signaling of inhibitory receptors. Here, we analyzed the role of the novel inhibitory receptor Ig-like transcript 2 (ILT2) in the pathogenesis of CLL. We observed that ILT2 expression was markedly reduced on leukemic cells, whereas it was increased on CD8 and CD4 T cells from CLL patients, particularly in those patients harboring chromosome 11q deletion, which includes the ATM gene. A deep dysregulation of ILT2 ligands expression in leukemia cells was also observed. ILT2 impaired the activation and proliferation of CD4 and CD8 T cells in CLL patients, but it had no effect in leukemic cells. ILT2 downregulated the production of IL-2 by CD4 T cells of CLL patients and induced the expression of cytokines that promote the survival of leukemic cells, such as IFN-?, by T cells. Importantly, ILT2 blockade restored the activation, proliferation and cytokine production of T cells. In conclusion, we describe a novel immune inhibitory pathway that is upregulated in CLL and delineate a new potential target to be explored in this disease. Twit Text FOAVip Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia ????Oncoimmunology http://www.kidney.de/pget.php?&tw=1&pmid=29123965 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29123965 #FOAvip English Wikipedia <ref>{{Cite pmid|29123965}}</ref> Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia #MMPMID29123965 Villa-Álvarez M; Lorenzo-Herrero S; Gonzalez-Rodriguez AP; López-Soto A; Payer AR; Gonzalez-Garcia E; Huergo-Zapico L; Gonzalez S Oncoimmunology 2017[]; 6 (10): ä PMID29123965show ga Chronic lymphocytic leukemia (CLL) is associated with a profound dysregulation of the immune system. Loss of T cell function is frequently caused in cancer by sustained signaling of inhibitory receptors. Here, we analyzed the role of the novel inhibitory receptor Ig-like transcript 2 (ILT2) in the pathogenesis of CLL. We observed that ILT2 expression was markedly reduced on leukemic cells, whereas it was increased on CD8 and CD4 T cells from CLL patients, particularly in those patients harboring chromosome 11q deletion, which includes the ATM gene. A deep dysregulation of ILT2 ligands expression in leukemia cells was also observed. ILT2 impaired the activation and proliferation of CD4 and CD8 T cells in CLL patients, but it had no effect in leukemic cells. ILT2 downregulated the production of IL-2 by CD4 T cells of CLL patients and induced the expression of cytokines that promote the survival of leukemic cells, such as IFN-?, by T cells. Importantly, ILT2 blockade restored the activation, proliferation and cytokine production of T cells. In conclusion, we describe a novel immune inhibitory pathway that is upregulated in CLL and delineate a new potential target to be explored in this disease. äIg-like transcript 2 (ILT2) suppresses T cell function in chronic lymp(epmc).pdf DeepDyve Pubget Overpricing